Please use this identifier to cite or link to this item: https://islhd.intersearch.com.au/islhdjspui/handle/1/5462
Title: Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study
Authors: Alexander W
Davis S
Ramakrishna R
Manoharan A.
ISLHD Author: Davis, Sarah
Ramakrishna, Raj
Keywords: Pharmacology
Date Published: 29-Sep-2020
Citation: J Hematol. 2020 Sep;9(3):55-61. doi: 10.14740/jh676. Epub 2020 Aug 14.
Keywords: Pharmacology
URI: https://islhd.intersearch.com.au/islhdjspui/handle/1/5462
DOI: 10.14740/jh676
Journal Title: J Hematol
Appears in Collections:Research publications from current and former ISLHD staff.

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.